|
PubHealth.info®
(a subsidiary of
PakMed) presents scientific information mainly
based on abstracts of articles published on a variety of public health issues/topics,
particularly encompassing
population planning, disease prevention, maternal and child health,
and communicable and
non-communicable diseases (like HIV AIDS, malaria, etc) that are
affecting a significant portion of population in developing and
developed
countries. Here you can find abstracts of articles published on a variety of public health
topics under category "Contraception
(Birth Control) and Family Planning".
Contraception (birth control)
is a regimen of one or more actions, devices, or medications followed in
order to deliberately prevent or reduce the likelihood of a woman
becoming pregnant or giving birth. Therefore contraception is the
utilization of various and sundry surgical procedures, devices,
practices, agents, or drugs with the intention of preventing conception
or impregnation (pregnancy). Methods and intentions typically termed
birth control may be considered a pivotal ingredient to family
planning. Birth control is a controversial political and ethical
issue in many cultures and religions, and although it is generally less
controversial than abortion specifically. |
|
|
| CATEGORY: |
Contraception (Birth Control) and Family Planning |
| Experimental and clinical aspects of the carcinogenic potential of steroid |
| International Journal of Fertility. 1968 Oct-Dec;13(4):273-286. |
| The available clinical and experimental findings relevant to the potential carcinogenic effects of estrogen- |
| progestogen contraceptives are examined. Most of the findings involve the estrogens in these preparations. Since |
| the endogenous estrogen secreted in a woman in 1 day has less biological activity than the daily estrogenic dose |
| contained in currently-employed preparations, even if endogenous formation is presumed suppressed, it is important |
| to seek potential carcinogenic effects of the pills. Findings are presented for breast, endometrial, and cervical |
| cancer. In each case no clear understanding exists. The evidence that estrogens, both endogenous and |
| exogenous, in some way modify the activity of breast cancer in women is particularly compelling. In some cases the |
| modification may be positive. Since oral contraceptives have been widely used only recently and since the effects of |
| known carcinogens have latency periods, available date for each of the 3 types of cancer is limited. Estrogen |
| administration has led to a wide variety of neoplasms in rats, mice, hamsters, rabbits, and dogs. The actions of an |
| estrogen and a progestogen given together in oral therapy may be different than the sum of the actions of the |
| estrogen given alone and the progestogen given alone: the possibilities of synergism and antagonism must be |
| considered. (PubHealth.info Document ID: CONT9T 1031-06) |
| PubHealth.info NOTE: The author(s) of this article titled, "Experimental and clinical aspects of the carcinogenic |
| potential of steroid contraceptives.", is(are) Hertz R. The source of this article is "International Journal of Fertility. |
| 1968 Oct-Dec;13(4):273-286.". This article was published in 1968 in English language(s). (PubHealth.info® |
| Document ID: CONT9T 1031-06. All rights reserved with PubHealth.info) PIN: 41031 |
|
|
|
© Copyrights PubHealth.info®,
an information portal on public health. All rights
reserved.
This page is optimized to be viewed by
Java script enabled Microsoft®
Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels. |